Yi-jiao Huang

State Key Laboratory Of Pathogen And Biosecurity
Beijing, 100071, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Viral protease-initiated lytic cell death as a universal antiviral mRNA therapy.

Viral protease-initiated lytic cell death as a universal antiviral mRNA therapy.

Journal: Cell

Published: December 07, 2025

Pan-membrane pyroptosis of liver induced by gasdermin-encoding mRNAs.

Pan-membrane pyroptosis of liver induced by gasdermin-encoding mRNAs.

Journal: National science review

Published: March 11, 2025

Rational design of a DNA-launched live attenuated vaccine against human enterovirus 71.

Rational design of a DNA-launched live attenuated vaccine against human enterovirus 71.

Journal: Virologica Sinica

Published: September 21, 2024

Neutralization of Omicron XBB.1 by booster vaccination with BA.4/5 monovalent mRNA vaccine.

Neutralization of Omicron XBB.1 by booster vaccination with BA.4/5 monovalent mRNA vaccine.

Journal: Cell discovery

Published: August 05, 2023

A pangolin-origin SARS-CoV-2-related coronavirus: infectivity, pathogenicity, and cross-protection by preexisting immunity.

A pangolin-origin SARS-CoV-2-related coronavirus: infectivity, pathogenicity, and cross-protection by preexisting immunity.

Journal: Cell discovery

Published: January 18, 2023

TRIM22 suppresses Zika virus replication by targeting NS1 and NS3 for proteasomal degradation.

TRIM22 suppresses Zika virus replication by targeting NS1 and NS3 for proteasomal degradation.

Journal: Cell & bioscience

Published: June 08, 2022

Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults.

Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults.

Journal: Cell research

Published: May 06, 2022

Rational development of a combined mRNA vaccine against COVID-19 and influenza.

Rational development of a combined mRNA vaccine against COVID-19 and influenza.

Journal: NPJ vaccines

Published: January 19, 2022

Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates.

Long-term stability and protection efficacy of the RBD-targeting COVID-19 mRNA vaccine in nonhuman primates.

Journal: Signal transduction and targeted therapy

Published: June 30, 2021

Identification of oligosaccharyltransferase as a host target for inhibition of SARS-CoV-2 and its variants.

Identification of oligosaccharyltransferase as a host target for inhibition of SARS-CoV-2 and its variants.

Journal: Cell discovery

Published: May 10, 2021

A Thermostable mRNA Vaccine against COVID-19.

A Thermostable mRNA Vaccine against COVID-19.

Journal: Cell

Published: June 04, 2020

G3BP1 promotes DNA binding and activation of cGAS.

G3BP1 promotes DNA binding and activation of cGAS.

Journal: Nature immunology

Published: July 06, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026